Mind Medicine (MindMed) Inc N.MMED.WA

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WS | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > The climb begins!

<< Previous

Bullboard Posts

Next >>

Post by Dantheman24on Jan 29, 2022 10:18am

523 Views

Post# 34374290

The climb begins!

Remember, MMED's all time high was $5.99, and that was on absolutely zero FDA approval! Now we have it! And once these drug companies get FDA approval the news will continue to get better and better, and it will climb back to its former glory and beyond! Anything under $2 is a steal! Let's sit back and enjoy next week! The bids on this stock are massively bigger then the asks! Great sign!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario